Dual-drug nanocarriers for gout therapy: targeted co-delivery of anti-inflammatory and urate-lowering agents: a review
Nisha Rata Karusan, Hairul Anuar Tajuddin, Nor Azlin Mat Radi, Rumman Karimah, Pratiwi Soesilawati, Syed Mahmood, Noraini Ahmad
TL;DR
This paper reviews how nanocarriers can deliver two types of drugs at once to better treat gout, reducing side effects and improving treatment effectiveness.
Contribution
The paper introduces the novel concept of using nanocarriers for dual-drug delivery in gout therapy, combining anti-inflammatory and urate-lowering agents.
Findings
Nanocarriers like liposomes and niosomes can co-deliver multiple drugs for gout treatment.
Functionalized nanocarriers can target acidic and oxidative environments in gout flares for controlled drug release.
Dual-drug delivery may improve therapeutic synergy and patient adherence in gout management.
Abstract
Gout, a prevalent form of inflammatory arthritis, arises from the deposition of monosodium urate crystals in joints due to chronic hyperuricemia. Current pharmacologic monotherapies such as xanthine oxidase inhibitors, uricosurics, NSAIDs, corticosteroids, and colchicine are often limited by inadequate dual-action efficacy, suboptimal bioavailability, and systemic side effects. Emerging nanocarrier-based drug delivery systems offer a promising alternative by improving pharmacokinetics and enhancing targeted delivery to inflamed tissues. While co-encapsulation of multiple therapeutics remains underexplored in gout, advances in related inflammatory diseases support its future application. This review explores the limitations of conventional gout therapies and highlights recent advancements in nanocarrier technologies, including liposomes, niosomes, and ethosomes, for delivering both…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGout, Hyperuricemia, Uric Acid · Medicinal plant effects and applications · Inflammasome and immune disorders